Welcome to our dedicated page for Stifel Fin news (Ticker: SF), a resource for investors and traders seeking the latest updates and insights on Stifel Fin stock.
Stifel Financial Corp. reports developments across a diversified financial-services business that includes wealth management, investment banking, lending, trading, and retail and institutional brokerage. Company news commonly covers earnings releases, selected operating data, client assets, fee-based assets, bank loans, client money market and insured products, treasury deposits, and capital returns on common and preferred stock.
Other updates describe Stifel’s platform expansion, including project finance for energy and infrastructure, venture banking and fund banking capabilities, public finance work for hospitals and health systems, and equity sales and research coverage. News also includes subsidiary activity such as Keefe, Bruyette & Woods index administration and changes affecting Stifel’s advisory and capital markets franchises.
Stifel Financial Corp. (NYSE: SF) announced a public offering of 12,000,000 depositary shares, totaling $300 million. Each share represents a 1/1000th interest in a 4.50% Non-Cumulative Perpetual Preferred Stock, Series D, with a liquidation preference of $25,000 per share. Dividends will be paid quarterly at an annual rate of 4.50%. The offering's net proceeds will be utilized to redeem outstanding Series A Preferred Stock and for general corporate purposes. The expected closing date is July 22, 2021.
Stifel Financial Corp. (NYSE: SF) announced the hiring of Bradley Canino as a Director and Equity Research Analyst for the biotechnology sector. Canino brings six years of experience, previously working at Credit Suisse and SVB Leerink, focusing on oncology. His recruitment enhances Stifel's research capabilities, particularly in healthcare, which is the firm's largest coverage sector. Stifel's healthcare research team consists of 52 professionals covering 263 companies. The firm has raised over $86 billion in capital for growth companies in healthcare since 2010.
Stifel Financial Corp. (NYSE: SF) announced the appointment of Charlie Smith as Managing Director in the Venture and Fund Banking Group, based in California. This hire aims to enhance Stifel's presence on the West Coast, particularly in the technology and life sciences sectors. Smith brings over 20 years of experience from City National Bank and Wells Fargo. The Venture and Fund Banking Group has successfully produced $2.5 billion in loan commitments and over $1 billion in deposits since its launch in 2018, indicating strong growth in its financial services offerings.
Summary not available.
Stifel Financial Corp. (NYSE: SF) announced a cash dividend of $0.15 per share on its common stock, payable on June 15, 2021, for shareholders on record by June 1, 2021. Additionally, dividends were declared for its Series A, B, and C Non-Cumulative Perpetual Preferred Stocks, amounting to approximately $0.390625 and $0.3828125 per depositary share, also payable on June 15, 2021. This reflects Stifel’s ongoing commitment to shareholder returns.
Stifel Financial Corp. (NYSE: SF) has hired Robert L. Rauch as Managing Director of Emerging Markets Debt Advisory, strengthening its full-service emerging markets offering. Rauch, with over 40 years of experience, previously held senior roles at Gramercy Funds Management, managing substantial corporate debt restructurings. Stifel's emerging markets platform has expanded since its 2019 launch, now comprising a team of 25 professionals. In its first year, the debt team achieved notable success, completing $32.4 billion in trades, demonstrating the growing significance of emerging markets in investment banking.
Stifel reported record net revenues of $1.1 billion for Q1 2021, marking a 24.3% year-over-year increase. Net income available to common shareholders reached $164.7 million, or $1.40 per diluted share, up from $81.7 million last year. Key drivers included strong performances in Global Wealth Management and Institutional Group segments. The company's assets also rose to $378.6 billion, an increase of 36.9% YoY. The Board declared a quarterly dividend of $0.15, a 36% increase.
Stifel Financial Corp. (NYSE: SF) will release its Q1 2021 financial results on April 27, 2021, before market opening. Following the release, a conference call hosted by Chairman and CEO Ronald J. Kruszewski will take place at 9:30 a.m. Eastern time. This call may feature forward-looking statements concerning the company's performance. Interested participants can join by dialing (877) 876-9938 and using conference ID 7880334. A webcast and presentation will also be available on Stifel's website, with a replay accessible after the call.
On April 7, 2021, Summer Street Capital Partners, based in Buffalo, NY, announced the sale of Curtis Bay Medical Waste Services to Aurora Capital Partners in Los Angeles. The terms of the deal remain undisclosed. Curtis Bay, headquartered in Baltimore, MD, is a leading medical waste solutions provider. Under Summer Street's ownership, Curtis Bay expanded its services and enhanced its operations, including strategic acquisitions and facility investments aimed at sustainability. The company operates the largest medical waste incinerator in the country and serves thousands of healthcare providers across the east coast.
Stifel Financial has appointed Thierry Perrein as Managing Director in the Fixed Income Capital Markets group, focusing on Financials and Real Estate Investment Trusts (REITs). Perrein, previously a top analyst at Wells Fargo, brings over 20 years of experience, having also held roles at Credit Suisse and Moody's. His expertise is expected to enhance Stifel's capabilities in fixed income research, building on the firm's recent recognition as a leading non-bulge bracket firm in this sector.